Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. Hormone. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea



Survival: 15.1 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
Hormone
   
Drugs:
Country: Korea
   
City/State/Province: Seoul
   
Hospital: Asan Medical Center, University of Ulsan College of Medicine
   
Journal: Link
   
Date: 6/2009

Description:
Patients:
This phase II study involved 27 patients with non-Hodgkin’s lymphoma, 63% of whom were male. Median patient age was not given, but 41% were over the age of 60.

Treatment:
Patients were treated with the chemotherapy agents etoposide, cytarabine, oxaliplatin, as well as the steroid hormone methylprednisolone.

Toxicities:
There was one treatment-related death due to neutropenic fever. Grade 4 leukopenia, anemia, and thrombocytopenia were also reported.

Results:
The median overall survival was 15.1 months.

Support:
Oxaliplatin was provided by Boryung Pharmaceutical.

Correspondence: Dr. Cheolwon Suh; email: csuh@amc.seoul.kr

E-mail to a Friend Email Physician More Information